Dr. Budoor AlMansour is a distinguished biotechnology expert and healthcare entrepreneur with over 17 years of experience bridging science, business, and investment across Saudi Arabia, Australia, China, the UAE, and global markets.

Dr. AlMansour co-founded Novo Genomics in Saudi Arabia, and as the Chief Operating Officer, she has been instrumental in raising significant startup funds and driving the company’s strategic vision. Her career includes leadership roles in G42 Healthcare and MGI.

With a PhD in Biotechnology from Australia, Dr. Budoor AlMansour combines scientific expertise with strong business acumen. She advises on AI-driven precision health and biotech investments, and mentors future leaders through the MISK Foundation and the Saudi Leadership Society.

Dr. AlMansour is a Global Executive MBA candidate at INSEAD. She is a recognized leader in fostering innovation, developing high-performing teams, and delivering impactful solutions that elevate business performance in competitive industries. Dr. Budoor AlMansour is committed to accelerating biotech and healthcare innovation in Saudi Arabia and beyond.